# First Northern Community Bancorp: financial statements, quarterly

FNRN · Nasdaq · CIK 1114927 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fnrn.md) · [Financials](/companies/fnrn/financials.md) · [Filings](/companies/fnrn/filings.md) · [Insiders](/companies/fnrn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fnrn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $k | [2,386](/filings/0001140361-23-052347.md) | [2,767 d](/filings/0001140361-24-012415.md) | [3,181](/filings/0001140361-24-025147.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [1,648](/filings/0001140361-24-045790.md) | [2,606 d](/filings/0001140361-25-007622.md) | [1,666](/filings/0001140361-25-018141.md) | [1,689](/filings/0001140361-25-029874.md) | [2,162](/filings/0001437749-25-033868.md) | [2,289 d](/filings/0001437749-26-008040.md) | [1,285](/filings/0001437749-26-015475.md) | [2,131](/filings/0001437749-26-026606.md) | [569](/filings/0001437749-25-033868.md) | [2,292 d](/filings/0001437749-26-008040.md) | [1,706](/filings/0001437749-26-015475.md) | [1,487](/filings/0001437749-26-026606.md) |
| Net income | $k | [4,619](/filings/0001140361-24-045790.md) | [6,882 d](/filings/0001140361-25-007622.md) | [4,276](/filings/0001437749-25-033868.md) | [4,424](/filings/0001437749-25-033868.md) | [5,488](/filings/0001437749-25-033868.md) | [5,846 d](/filings/0001437749-26-008040.md) | [3,671](/filings/0001437749-26-026606.md) | [5,466](/filings/0001437749-26-026606.md) | [6,013](/filings/0001437749-25-033868.md) | [5,978 d](/filings/0001437749-26-008040.md) | [5,906](/filings/0001437749-26-026606.md) | [4,728](/filings/0001437749-26-026606.md) |
| Diluted EPS | $ per share | [0.30](/filings/0001140361-24-045790.md) | not reported | [0.26](/filings/0001140361-25-018141.md) | [0.27](/filings/0001140361-25-029874.md) | [0.34](/filings/0001437749-25-033868.md) | not reported | [0.22](/filings/0001437749-26-015475.md) | [0.33](/filings/0001437749-26-026606.md) | [0.38](/filings/0001437749-25-033868.md) | not reported | [0.36](/filings/0001437749-26-015475.md) | [0.29](/filings/0001437749-26-026606.md) |
| Basic EPS | $ per share | [0.30](/filings/0001140361-24-045790.md) | not reported | [0.27](/filings/0001140361-25-018141.md) | [0.28](/filings/0001140361-25-029874.md) | [0.35](/filings/0001437749-25-033868.md) | not reported | [0.22](/filings/0001437749-26-015475.md) | [0.33](/filings/0001437749-26-026606.md) | [0.39](/filings/0001437749-25-033868.md) | not reported | [0.37](/filings/0001437749-26-015475.md) | [0.29](/filings/0001437749-26-026606.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [197](/filings/0001140361-23-052347.md) | [149](/filings/0001140361-25-007622.md) | [187](/filings/0001140361-24-025147.md) | [182](/filings/0001140361-24-036573.md) | [164](/filings/0001140361-24-045790.md) | [119](/filings/0001437749-26-008040.md) | [112](/filings/0001140361-25-018141.md) | [127](/filings/0001140361-25-029874.md) | [150](/filings/0001437749-25-033868.md) | [146](/filings/0001437749-26-026606.md) | [140](/filings/0001437749-26-015475.md) | [113](/filings/0001437749-26-026606.md) |
| Total assets | $m | [1,902](/filings/0001140361-23-052347.md) | [1,872](/filings/0001140361-25-007622.md) | [1,887](/filings/0001140361-24-025147.md) | [1,888](/filings/0001140361-24-036573.md) | [1,931](/filings/0001140361-24-045790.md) | [1,892](/filings/0001437749-26-008040.md) | [1,876](/filings/0001140361-25-018141.md) | [1,872](/filings/0001140361-25-029874.md) | [1,908](/filings/0001437749-25-033868.md) | [1,911](/filings/0001437749-26-026606.md) | [1,925](/filings/0001437749-26-015475.md) | [1,926](/filings/0001437749-26-026606.md) |
| Total liabilities | $m | [1,766](/filings/0001140361-23-052347.md) | [1,713](/filings/0001140361-25-007622.md) | [1,725](/filings/0001140361-24-025147.md) | [1,722](/filings/0001140361-24-036573.md) | [1,749](/filings/0001140361-24-045790.md) | [1,715](/filings/0001437749-26-008040.md) | [1,688](/filings/0001140361-25-018141.md) | [1,677](/filings/0001140361-25-029874.md) | [1,703](/filings/0001437749-25-033868.md) | [1,699](/filings/0001437749-26-026606.md) | [1,711](/filings/0001437749-26-015475.md) | [1,709](/filings/0001437749-26-026606.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001437749-26-008040.md) | not reported | not reported | not reported | [0.0](/filings/0001437749-26-008040.md) | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001437749-26-008040.md) | not reported | not reported | not reported | [0.0](/filings/0001437749-26-008040.md) | not reported | not reported |
| Shareholders' equity | $m | [136](/filings/0001140361-24-045790.md) | [159](/filings/0001437749-26-008040.md) | [162](/filings/0001437749-25-033868.md) | [166](/filings/0001437749-25-033868.md) | [182](/filings/0001437749-25-033868.md) | [176](/filings/0001437749-26-026606.md) | [188](/filings/0001437749-26-026606.md) | [195](/filings/0001437749-26-026606.md) | [205](/filings/0001437749-25-033868.md) | [212](/filings/0001437749-26-026606.md) | [214](/filings/0001437749-26-026606.md) | [217](/filings/0001437749-26-026606.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [12.0 d](/filings/0001140361-24-045790.md) | [2.3 d](/filings/0001140361-25-007622.md) | [2.7](/filings/0001140361-25-018141.md) | [2.5 d](/filings/0001140361-25-029874.md) | [8.0 d](/filings/0001437749-25-033868.md) | [6.3 d](/filings/0001437749-26-008040.md) | [3.4](/filings/0001437749-26-015475.md) | [2.5 d](/filings/0001437749-26-026606.md) | [(6.6) d](/filings/0001437749-25-033868.md) | [7.6 d](/filings/0001437749-26-008040.md) | [4.3](/filings/0001437749-26-015475.md) | [3.5 d](/filings/0001437749-26-026606.md) |
| Capital expenditure | $m | [0.5 d](/filings/0001140361-24-045790.md) | [0.2 d](/filings/0001140361-25-007622.md) | [0.0](/filings/0001140361-25-018141.md) | [0.1 d](/filings/0001140361-25-029874.md) | [0.1 d](/filings/0001437749-25-033868.md) | [0.1 d](/filings/0001437749-26-008040.md) | [0.1](/filings/0001437749-26-015475.md) | [0.3 d](/filings/0001437749-26-026606.md) | [0.8 d](/filings/0001437749-25-033868.md) | [0.4 d](/filings/0001437749-26-008040.md) | [0.5](/filings/0001437749-26-015475.md) | [0.6 d](/filings/0001437749-26-026606.md) |
| Share repurchases | $m | [0.0 d](/filings/0001140361-24-045790.md) | [0.0 d](/filings/0001140361-25-007622.md) | [0.0](/filings/0001140361-25-018141.md) | [1.2 d](/filings/0001140361-25-029874.md) | [1.6 d](/filings/0001437749-25-033868.md) | [1.0 d](/filings/0001437749-26-008040.md) | [1.3](/filings/0001437749-26-015475.md) | [0.9 d](/filings/0001437749-26-026606.md) | [1.1 d](/filings/0001437749-25-033868.md) | [1.5 d](/filings/0001437749-26-008040.md) | [1.2](/filings/0001437749-26-015475.md) | [0.2 d](/filings/0001437749-26-026606.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [14.6](/filings/0001140361-23-052347.md) | [15.3](/filings/0001140361-24-025147.md) | [15.3](/filings/0001140361-24-036573.md) | [15.4](/filings/0001140361-24-045790.md) | [16.1](/filings/0001140361-25-018141.md) | [16.1](/filings/0001140361-25-029874.md) | [16.1](/filings/0001437749-25-033868.md) | [16.7](/filings/0001437749-26-015475.md) | [16.6](/filings/0001437749-26-026606.md) | [15.8](/filings/0001437749-25-033868.md) | [16.5](/filings/0001437749-26-015475.md) | [16.5](/filings/0001437749-26-026606.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 16,395,303 at 2026-08-05, from the cover of the [10-Q filed 2026-08-07](/filings/0001437749-26-026606.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:33 ET. No prices; not investment advice.